Literature DB >> 21723253

SERPINB13 is a novel RUNX1 target gene.

Anita Boyapati1, Bing Ren, Dong-Er Zhang.   

Abstract

RUNX1 is a critical transcription factor during embryogenesis and neoplastic disease. To identify novel transcriptional targets of RUNX1 in the context of chromatin, we performed genome wide location analysis (ChIP-on-chip). Here we report that SERPINB13, a gene downregulated in head and neck cancers, is a novel RUNX1transcriptional target. RUNX1 binds the SERPINB13 promoter in chromatin to repress its transcription. Mutation of either RUNX1 binding site in the SERPINB13 promoter increased the activity of the promoter. Finally, overexpression of RUNX1 and concomitant decrease in SERPINB13 expression led to increased activity of cathepsin K, an enzyme inhibited by SERPINB13. These data demonstrate that RUNX1 is an important regulator of SERPINB13 and cathepsin K activity.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21723253      PMCID: PMC3312028          DOI: 10.1016/j.bbrc.2011.06.107

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  40 in total

1.  Deletion of an AML1-ETO C-terminal NcoR/SMRT-interacting region strongly induces leukemia development.

Authors:  Ming Yan; Sebastien A Burel; Luke F Peterson; Eiki Kanbe; Hiromi Iwasaki; Anita Boyapati; Robert Hines; Koichi Akashi; Dong-Er Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-29       Impact factor: 11.205

2.  Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization.

Authors:  M Gowen; F Lazner; R Dodds; R Kapadia; J Feild; M Tavaria; I Bertoncello; F Drake; S Zavarselk; I Tellis; P Hertzog; C Debouck; I Kola
Journal:  J Bone Miner Res       Date:  1999-10       Impact factor: 6.741

Review 3.  The RUNX genes: gain or loss of function in cancer.

Authors:  Karen Blyth; Ewan R Cameron; James C Neil
Journal:  Nat Rev Cancer       Date:  2005-05       Impact factor: 60.716

4.  Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype.

Authors:  Joseph D Growney; Hirokazu Shigematsu; Zhe Li; Benjamin H Lee; Jennifer Adelsperger; Rebecca Rowan; David P Curley; Jeffery L Kutok; Koichi Akashi; Ifor R Williams; Nancy A Speck; D Gary Gilliland
Journal:  Blood       Date:  2005-03-22       Impact factor: 22.113

5.  Headpin: a serpin with endogenous and exogenous suppression of angiogenesis.

Authors:  Thomas D Shellenberger; Abhijit Mazumdar; Ying Henderson; Katrina Briggs; Mary Wang; Chandrani Chattopadhyay; Arumugam Jayakumar; Mitchell Frederick; Gary L Clayman
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

6.  A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma.

Authors:  Jesús Planagumà; María Díaz-Fuertes; Antonio Gil-Moreno; Miguel Abal; Marta Monge; Angel García; Teresa Baró; Timothy M Thomson; Jordi Xercavins; Francesc Alameda; Jaume Reventós
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

7.  Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells.

Authors:  Orit Kollet; Ayelet Dar; Shoham Shivtiel; Alexander Kalinkovich; Kfir Lapid; Yejezkel Sztainberg; Melania Tesio; Robert M Samstein; Polina Goichberg; Asaf Spiegel; Ari Elson; Tsvee Lapidot
Journal:  Nat Med       Date:  2006-05-21       Impact factor: 53.440

8.  Cloning and characterization of hurpin (protease inhibitor 13): A new skin-specific, UV-repressible serine proteinase inhibitor of the ovalbumin serpin family.

Authors:  H F Abts; T Welss; A Mirmohammadsadegh; K Köhrer; G Michel; T Ruzicka
Journal:  J Mol Biol       Date:  1999-10-15       Impact factor: 5.469

Review 9.  Runx1/AML1 in normal and abnormal hematopoiesis.

Authors:  Tetsuya Yamagata; Kazuhiro Maki; Kinuko Mitani
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

Review 10.  Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells.

Authors:  Toshiyuki Nomura; Nobuhiko Katunuma
Journal:  J Med Invest       Date:  2005-02
View more
  2 in total

1.  Functionally deregulated AML1/RUNX1 cooperates with BCR-ABL to induce a blastic phase-like phenotype of chronic myelogenous leukemia in mice.

Authors:  Kiyoko Yamamoto; Shinobu Tsuzuki; Yosuke Minami; Yukiya Yamamoto; Akihiro Abe; Koichi Ohshima; Masao Seto; Tomoki Naoe
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

2.  Stable depletion of RUNX1-ETO in Kasumi-1 cells induces expression and enhanced proteolytic activity of Cathepsin G and Neutrophil Elastase.

Authors:  Caroline Schoenherr; Katharina Wohlan; Iris Dallmann; Andreas Pich; Jan Hegermann; Arnold Ganser; Denise Hilfiker-Kleiner; Olaf Heidenreich; Michaela Scherr; Matthias Eder
Journal:  PLoS One       Date:  2019-12-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.